These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 844493)

  • 41. 3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake.
    Bøgesø KP; Christensen AV; Hyttel J; Liljefors T
    J Med Chem; 1985 Dec; 28(12):1817-28. PubMed ID: 2999402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum.
    Hunt P; Kannengiesser M; Raynaud J
    J Pharm Pharmacol; 1974 May; 26(5):370-1. PubMed ID: 4152974
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanisms of transport for the uptake and release of biogenic amines in nerve endings.
    Bogdanski DF
    Adv Exp Med Biol; 1976; 69():291-305. PubMed ID: 133592
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization of synaptosomal dopamine uptake in post-mortem brain regions of schizophrenics.
    Hetey L; Berg R; Schlesinger T
    Neurochem Pathol; 1987 Dec; 7(3):221-32. PubMed ID: 3453902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies in postmortem dopamine uptake. I. Kinetic characterization of the synaptosomal dopamine uptake in rat and human brain after postmortem storage and cryopreservation. Comparison with noradrenaline and serotonin uptake.
    Haberland N; Hetey L
    J Neural Transm; 1987; 68(3-4):289-301. PubMed ID: 3559541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methadone inhibits serotonin and norephinephrine uptake into rat brain synaptosomes and synaptic vesicles in vitro but not in vivo.
    Slotkin TA; Seidler FJ; Whitmore WL
    Eur J Pharmacol; 1978 Jun; 49(4):357-62. PubMed ID: 668807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereoselective inhibition of synaptosomal catecholamine uptake by nomifensine.
    Schacht U; Leven M
    Eur J Pharmacol; 1984 Feb; 98(2):275-7. PubMed ID: 6714310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the effects of the selective 5-HT uptake inhibitor WY 27587 on 5-HT uptake into platelets and synaptosomes in the rat.
    Billingsley AJ; Brammer NT; Wood MD; Minchin MC
    Neuropharmacology; 1989 Jan; 28(1):33-6. PubMed ID: 2522598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformationally rigid amphetamine analogs as inhibitors of monoamine uptake by brain synaptosomes.
    Tuomisto J; Tuomisto L; Pazdernik TL
    J Med Chem; 1976 May; 19(5):725-7. PubMed ID: 1271416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antihistamine effect on synaptosomal uptake of serotonin, norepinephrine and dopamine.
    Brown PA; Vernikos J
    Eur J Pharmacol; 1980 Jul; 65(1):89-92. PubMed ID: 7398780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of nomifensine and its metabolites on dihydropteridine reductase.
    Shen RS; Sheng WL; Abell CW
    J Pharm Pharmacol; 1984 Jun; 36(6):411-3. PubMed ID: 6146678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine.
    Feuerstein TJ; Hertting G; Lupp A; Neufang B
    Br J Pharmacol; 1986 Jul; 88(3):677-84. PubMed ID: 3742155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of nomifensine on the isolated vas deferens of the rat.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):94-102. PubMed ID: 508001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.
    Taylor D; Ho BT
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):67-75. PubMed ID: 684280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of conformationally restrained analogues of serotonin on its uptake and binding in rat brain.
    Friedman E; Meller E; Hallock M
    J Neurochem; 1981 Mar; 36(3):931-7. PubMed ID: 7205283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.